Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

HKG:1877 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,770	2,502	3,788	5,997	3,507	3,385
Short-Term Investments	-	-	-	17.93	-	-
Trading Asset Securities	500.77	430.51	-	-	-	0.02
Cash & Short-Term Investments	3,270	2,933	3,788	6,015	3,507	3,385
Cash Growth	7.42%	-22.58%	-37.02%	71.53%	3.59%	177.26%
Accounts Receivable	439.66	509.82	483.23	232.73	1,301	664.44
Other Receivables	2.82	36.44	374.01	78.81	28.05	22.84
Receivables	442.48	546.26	857.23	314.25	1,329	687.28
Inventory	516.03	584.47	538.05	599.02	484.6	343.43
Prepaid Expenses	-	-	-	239.82	-	-
Other Current Assets	216.1	220.38	387.59	36.94	524.79	283
Total Current Assets	4,445	4,284	5,571	7,205	5,845	4,699
Property, Plant & Equipment	4,391	4,195	3,809	3,278	2,801	2,377
Long-Term Investments	1,599	1,226	1,133	1,292	1,485	422.9
Other Intangible Assets	575.09	521.41	546.96	98.91	264.98	162.09
Long-Term Deferred Tax Assets	89.64	87.05	103.4	228.43	88.55	26.11
Long-Term Deferred Charges	10.57	6.12	12.6	-	27.79	13.24
Other Long-Term Assets	577.38	461.94	167.14	473.39	522.34	297.73
Total Assets	11,688	10,782	11,343	12,576	11,035	7,997
Accounts Payable	954.85	115.9	125.19	370.23	63.17	55.69
Accrued Expenses	223.26	901.44	1,046	917.21	1,603	826.28
Short-Term Debt	854.21	678.11	452.44	391.75	-	21.23
Current Portion of Long-Term Debt	639.38	216.5	86.96	-	10.6	231.11
Current Portion of Leases	-	30.29	35.93	43.66	34.47	25.22
Current Income Taxes Payable	28.43	12.41	17.98	-	63.08	-
Current Unearned Revenue	15.93	8.17	146.3	0.44	45.8	43.14
Other Current Liabilities	32.56	531.11	527.92	50.96	181.59	269.79
Total Current Liabilities	2,749	2,494	2,438	1,774	2,001	1,472
Long-Term Debt	2,030	1,980	1,196	839.58	490	542.22
Long-Term Leases	61.61	26.31	17.45	46.59	93.13	30.99
Long-Term Unearned Revenue	167.61	181.91	183.46	121.62	122.46	122.65
Other Long-Term Liabilities	384.4	168	187.15	-	11.5	1.28
Total Liabilities	5,393	4,850	4,022	2,782	2,719	2,170
Common Stock	1,027	985.69	985.69	982.87	910.76	872.5
Additional Paid-In Capital	16,317	15,407	15,395	-	11,423	8,632
Retained Earnings	-10,937	-10,341	-9,060	-	-4,389	-3,668
Treasury Stock	-30.89	-30.89	-26.89	-	-	-
Comprehensive Income & Other	-160.08	-159.94	-142.07	8,519	0.21	-9.39
Total Common Equity	6,216	5,860	7,151	9,501	7,945	5,828
Minority Interest	79.16	71.71	169.39	292.83	371.28	-0
Shareholders' Equity	6,295	5,932	7,321	9,794	8,316	5,828
Total Liabilities & Equity	11,688	10,782	11,343	12,576	11,035	7,997
Total Debt	3,586	2,931	1,789	1,322	628.19	850.78
Net Cash (Debt)	-315.21	1.82	2,000	4,693	2,878	2,534
Net Cash Growth	-	-99.91%	-57.39%	63.05%	13.58%	608.08%
Net Cash Per Share	-0.32	0.00	2.03	5.12	3.23	3.08
Filing Date Shares Outstanding	1,013	984.87	985.01	982.87	910.76	872.5
Total Common Shares Outstanding	1,013	984.87	985.01	982.87	910.76	872.5
Working Capital	1,696	1,790	3,133	5,431	3,843	3,226
Book Value Per Share	6.13	5.95	7.26	9.67	8.72	6.68
Tangible Book Value	5,641	5,339	6,604	9,403	7,680	5,666
Tangible Book Value Per Share	5.57	5.42	6.70	9.57	8.43	6.49
Buildings	-	1,379	1,419	-	891.83	880.3
Machinery	-	2,022	1,921	1,522	1,419	1,247
Construction In Progress	-	1,859	1,325	1,048	801.93	415.55
Leasehold Improvements	-	-	-	65.57	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.